Medicinova (MNOV) Return on Equity [ROE] (2009 - 2026)
Medicinova (MNOV) reported Return on Equity [ROE] of -28.97% for Q2 2026, down 4.58 percentage points from -24.39% a year earlier.
Analysis
Medicinova (MNOV) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Medicinova posted Return on Equity [ROE] of -25.50%, down 6.27 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -6.55 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -19.24% in FY2024 (-6.31 pp), -12.93% in FY2023 (+5.35 pp), -18.28% in FY2022 (-5.20 pp) and -13.08% in FY2021 (+5.87 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2017.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2021 (a gain of 7.24 percentage points); the low point was Q2 2025 (a drop of 10.55 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Medicinova | 68.91 Mn | -47.24 Mn | 317,759.00 | 3,194.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,194.99% |
| Mar 31, 2026 | 641.58% |
| Dec 31, 2025 | -28.03% |
| Sep 30, 2025 | -2,109.15% |
| Jun 30, 2025 | -1,554.82% |
| Mar 31, 2025 | -208.28% |
| Dec 31, 2024 | -20.58% |
| Sep 30, 2024 | -18,305.27% |
| Jun 30, 2024 | -13,946.95% |
| Mar 31, 2024 | -13,777.54% |
| Dec 31, 2023 | -13,497.80% |
| Sep 30, 2023 | -10,048.72% |
| Jun 30, 2023 | -14,230.36% |
| Mar 31, 2023 | -15,396.54% |
| Dec 31, 2022 | -15,481.19% |
| Sep 30, 2022 | -4,068.09% |
| Jun 30, 2022 | -3,781.07% |
| Mar 31, 2022 | -3,912.89% |
| Dec 31, 2021 | -11.92% |
| Sep 30, 2021 | -9,174.90% |
API Access
Medicinova Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MNOV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "MNOV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=MNOV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();